Stocks / ALC vs RMD

Alcon Inc. (ALC) vs ResMed Inc. (RMD)

Alcon Inc. and ResMed Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

RMD is the larger company ($33.4B vs $32.2B). On the fundamentals, RMD grows revenue faster (12.1% vs 6.1%); RMD earns a higher net margin (26.9% vs 9.4%); RMD has the stronger return on equity (23.1% vs 4.5%). Over the last five years, ALC returned -4.2% vs -13.4%. Neither shows an obvious red flag in the filings. Full numbers below — the stronger figure on each row is in green.

AI verdict — ALC vs RMD, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Alcon Inc. (ALC)ResMed Inc. (RMD)
Market cap$32.2B$33.4B
Revenue (latest FY)$10.40B$5.65B
Net income (latest FY)$980.00M$1.52B
Revenue growth (5y CAGR)6.1%12.1%
Net margin9.4%26.9%
Return on equity4.5%23.1%
P/E ratio39.622.2
Dividend yield0.5%1.1%
Profitable years (of last 10)410
Positive free cash flowYesYes

Performance — ALC vs RMD

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Alcon Inc. (ALC)ResMed Inc. (RMD)
1-year return-24.8%-11.5%
3-year return-18.6%55.1%
5-year return-4.2%-13.4%
10-year return302.6%
52-week range$61.84–$92.55$180.27–$284.87

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full ALC vs RMD breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open ALC's full financials →   Open RMD's full financials →

More comparisons

Frequently asked questions

Which is bigger, ALC or RMD?

ResMed Inc. is larger by market capitalization — $33.4B versus $32.2B.

Which grows faster, ALC or RMD?

Over the last five fiscal years, ResMed Inc. grew revenue faster — 12.1%/yr versus 6.1%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

ALC fundamentals → · RMD fundamentals → · All 1,500+ companies → · Free screener →